FDA Drug recall D-1486-2014
OXYCODONE HYDROCHLORIDE C II Oral Solution USP, 5 mg/5 mL, 15 mL Vial, Rx only
- FDA Drug
- Class III
- terminated
- Published 2014-08-06
On 2014-08-06 the FDA classified a Class III recall of OXYCODONE HYDROCHLORIDE C II Oral Solution USP, 5 mg/5 mL, 15 mL Vial, Rx only by Boehringer Ingelheim Roxane, citing failed Stability Specifications: Out of specification result for preservative sodium benzoate.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1486-2014 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2014-07-28 |
| Published | 2014-08-06 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Boehringer Ingelheim Roxane |
| Distribution | US |
Product
OXYCODONE HYDROCHLORIDE C II Oral Solution USP, 5 mg/5 mL, 15 mL Vial, Rx only. Boehringer Ingelheim, Roxane Laboratories. Roxane Laboratories, Inc. Columbus, Ohio 43216. NDC: 0054-0523-41.
Reason
Failed Stability Specifications: Out of specification result for preservative sodium benzoate.
Identifiers
| code_info | Lot #: 360241A, Expiry: 05/2015. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1486-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.